Skip to content

4Accepted Jan 22, 6:54 PM ET

Decheng Capital China Life Sciences USD Fund III, L.P. 4

ALPNALPINE IMMUNE SCIENCES, INC.

Accepted (ET)

6:54 PM

Jan 22, 2024

Filed

Jan 22, 2024

Documents

1

Size

9.8 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.